Lisinopril dihydrate( —— )

Catalog No. M16115 CAS No. 83915-83-7

A angiotensin-converting enzyme (ACE) inhibitor for treatment of hypertension, heart failure, and after heart attacks.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
100MG	28	In Stock
200MG	Get Quote	In Stock
500MG	53	In Stock
1G	85	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Lisinopril dihydrate
Note

Research use only, not for human use.
Brief Description

A angiotensin-converting enzyme (ACE) inhibitor for treatment of hypertension, heart failure, and after heart attacks.
Description

A angiotensin-converting enzyme (ACE) inhibitor for treatment of hypertension, heart failure, and after heart attacks.Hypertension Approved(In Vitro):Lisinopri dihydrate is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Lisinopril may be used to treat hypertension and symptomatic congestive heart failure, to improve survival in certain individuals following myocardial infarction, and to prevent progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy.
In Vitro

Lisinopri dihydrate is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Lisinopril may be used to treat hypertension and symptomatic congestive heart failure, to improve survival in certain individuals following myocardial infarction, and to prevent progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy.
In Vivo

——
Synonyms

——
Pathway

Metabolic Enzyme/Protease
Target

ACE
Recptor

ACE|MRP1
Research Area

Cardiovascular Disease
Indication

Hypertension

Chemical Information

CAS Number

83915-83-7
Formula Weight

441.5185
Molecular Formula

C21H35N3O7
Purity

>98% (HPLC)
Solubility

DMSO: < 4.4 mg/mL
SMILES

C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O.O.O
Chemical Name

L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, hydrate (1:2)